Suppression_NN
of_IN
NF-kappaB_NN
activation_NN
in_IN
normal_JJ
T_NN
cells_NNS
by_IN
supernatant_JJ
fluid_NN
from_IN
human_JJ
renal_JJ
cell_NN
carcinomas_NNS
._.

T_NN
lymphocytes_NNS
from_IN
patients_NNS
with_IN
renal_JJ
cell_NN
carcinoma_NN
-LRB-_-LRB-
RCC_NN
-RRB-_-RRB-
show_VBP
reduced_VBN
immune_JJ
function_NN
and_CC
impaired_JJ
activation_NN
of_IN
the_DT
transcription_NN
factor_NN
,_,
NF-kappaB_NN
._.

We_PRP
determined_VBD
the_DT
mechanism_NN
of_IN
NF-kappaB_NN
suppression_NN
in_IN
T_NN
cells_NNS
of_IN
RCC_NN
patient_NN
and_CC
determined_VBD
whether_IN
supernatant_JJ
fluid_NN
from_IN
RCC_NN
explants_NNS
-LRB-_-LRB-
RCC-S_NNS
-RRB-_-RRB-
induced_VBD
the_DT
same_JJ
phenotype_NN
of_IN
NF-kappaB_NN
suppression_NN
in_IN
normal_JJ
T_NN
cells_NNS
that_WDT
is_VBZ
observed_VBN
in_IN
patient_NN
T_NN
cells_NNS
._.

The_DT
pattern_NN
of_IN
kappaB-binding_JJ
activity_NN
in_IN
T_NN
cells_NNS
of_IN
RCC_NN
patient_NN
was_VBD
altered_VBN
as_IN
compared_VBN
to_TO
that_DT
seen_VBN
in_IN
T_NN
cells_NNS
obtained_VBN
from_IN
normal_JJ
volunteers_NNS
._.

In_IN
some_DT
patients_NNS
,_,
no_DT
activation_NN
of_IN
RelA\/NFkappaB1-binding_JJ
activity_NN
was_VBD
detectable_JJ
,_,
while_IN
in_IN
others_NNS
kappaB-binding_JJ
activity_NN
was_VBD
modestly_RB
induced_VBN
but_CC
the_DT
duration_NN
was_VBD
reduced_VBN
._.

IkappaBalpha_NN
was_VBD
degraded_VBN
normally_RB
following_VBG
stimulation_NN
in_IN
both_CC
normal_JJ
controls_NNS
and_CC
T_NN
cells_NNS
from_IN
RCC_NN
patients_NNS
._.

RCC-S_NNS
did_VBD
not_RB
alter_VB
the_DT
cytoplasmic_JJ
levels_NNS
of_IN
RelA_NN
and_CC
NF-kappaB1_NN
but_CC
did_VBD
suppress_VB
their_PRP$
nuclear_JJ
localization_NN
and_CC
inhibited_VBD
the_DT
activation_NN
of_IN
RelA\/NF-kappaB_NN
1_CD
binding_VBG
complexes_NNS
._.

These_DT
results_NNS
show_VBP
that_IN
RCC-S_NNS
can_MD
induce_VB
in_IN
normal_JJ
T_NN
cells_NNS
the_DT
same_JJ
phenotype_NN
of_IN
impaired_JJ
NF-kappaB_NN
activation_NN
that_WDT
is_VBZ
detected_VBN
in_IN
T_NN
cells_NNS
of_IN
RCC_NN
patient_NN
._.

It_PRP
also_RB
appears_VBZ
that_IN
NF-kappaB_NN
suppression_NN
by_IN
RCC-S_NNS
may_MD
contribute_VB
to_TO
the_DT
immunosuppression_NN
of_IN
host_NN
immunity_NN
._.

